Routine checks for spurious drugs by drug inspectors from the desk of
Drugs Control Department
Karnataka
https://chat.whatsapp.com/IECdk7yCsmJ9kSNOo7Tx0k
Inspections conducted by drug inspectors often reveal whether a medicine is spurious or misbranded through rigorous sampling and laboratory testing.
during routine checks at manufacturing units, pharmacies or distribution channels, inspectors collect samples of medicines, which are sent to government-approved laboratories for analysis.
“If a medicine fails to meet the prescribed quality standards set by regulatory authorities such as the Drugs Controller General of India (DCGI), contains incorrect or harmful ingredients, or is falsely labelled, it is classified as spurious. Similarly, if the labelling is inaccurate, misleading or fails to adhere to regulatory guidelines, the medicine is marked as misbranded. Once identified, the drugs are labelled accordingly, and immediate action is taken to prevent their distribution and sale,” the official said.
https://chat.whatsapp.com/IECdk7yCsmJ9kSNOo7Tx0k
These medicines pose significant risks to public health as they can lead to ineffective treatment, adverse reactions and harm antibiotic resistance, the official said, adding that regulatory authorities, on a regular basis, detect spurious or misbranded medicines through inspections, testing, consumer complaints, and monitoring of manufacturing processes.
